Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2024

Dec 12, 2024

30870_dirs_2024-12-12_e25534a4-b28d-43b1-81a9-4abe75d85550.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2024-12-11

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-11 Common Stock M 1780 $7.37 Acquired 40241 Direct
2024-12-11 Common Stock S 1780 $50.42 Disposed 38461 Direct
2024-12-11 Common Stock M 10092 $7.37 Acquired 48553 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-11 Non-Qualified Stock Option (Right to Buy) $7.37 M 1780 Disposed 2025-01-02 Common Stock (1780) Direct
2024-12-11 Non-Qualified Stock Option (Right to Buy) $7.37 M 10092 Disposed 2025-01-02 Common Stock (10092) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 83 Indirect